Brian Kavanagh, MD, MPH

Professional Titles

• Department Chair

Recognitions

• Top Doctor, 5280 Magazine (2023)

Publications

• Pike LRG, Miao E, Boe LA, Patil T, Imber BS, Myall NJ, Pollom EL, Hui C, Qu V, Langston J, Chiang V, Grant M, Goldberg SB, Palmer JD, Prasad RN, Wang TJC, Lee A, Shu CA, Chen LN, Thomas NJ, Braunstein SE, Kavanagh BD, Camidge DR, Rusthoven CG. Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From EGFR and ALK Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC). J Clin Oncol. 2024 Oct 20;42(30):3606-3617. PubMed PMID: 39047224
• Tsui DCC, Holt DE, Patil T, Staley A, Gao D, Kavanagh BD, Schenk EL, Rusthoven CG, Camidge DR. The Role of Local Therapy for Oligo-Progressive Disease in Oncogene-Addicted Non-Small-Cell Lung Cancer. Adv Radiat Oncol. 2024 Jul;9(7):101516. PubMed PMID: 38868503
• Cioffi G, Ascha MS, Waite KA, Dmukauskas M, Wang X, Royce TJ, Calip GS, Waxweiler T, Rusthoven CG, Kavanagh BD, Barnholtz-Sloan JS. Sex Differences in Odds of Brain Metastasis and Outcomes by Brain Metastasis Status after Advanced Melanoma Diagnosis. Cancers (Basel). 2024 May 3;16(9). PubMed PMID: 38730723
• Lombardo J, Castillo E, Castillo R, Miller R, Jones B, Miften M, Kavanagh B, Dicker A, Boyle C, Leiby B, Banks J, Simone NL, Movsas B, Grills I, Guerrero T, Rusthoven CG, Vinogradskiy Y. Prospective Trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report. Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):593-602. PubMed PMID: 38614278
• Bayat F, Miller B, Park Y, Yu Z, Alexeev T, Thomas D, Stuhr K, Kavanagh B, Miften M, Altunbas C. 2D antiscatter grid and scatter sampling based CBCT method for online dose calculations during CBCT guided radiation therapy of pelvis. Med Phys. 2024 Apr;51(4):3053-3066. PubMed PMID: 38043086
• Bayat F, Miller B, Park Y, Yu Z, Alexeev T, Thomas D, Stuhr K, Kavanagh B, Miften M, Altunbas C. 2D antiscatter grid and scatter sampling based CBCT method for online dose calculations during CBCT guided radiation therapy of pelvis. Med Phys. 2023 Dec 3. [Epub ahead of print] PubMed PMID: 38043086
• Bayat F, Miller B, Park Y, Yu Z, Alexeev T, Thomas D, Stuhr K, Kavanagh B, Miften M, Altunbas C. A 2D antiscatter grid and scatter sampling based CBCT method for online dose calculations during CBCT guided radiation therapy of pelvis. ArXiv. 2023 Oct 10. PubMed PMID: 37873015
• Ghassemi N, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Werner-Wasik M, Miller R, Barta JA, Grills I, Leiby BE, Guerrero T, Rusthoven CG, Vinogradskiy Y. Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial. Radiother Oncol. 2023 Oct;187:109821. PubMed PMID: 37516361
• Rusthoven CG, Staley AW, Gao D, Yomo S, Bernhardt D, Wandrey N, El Shafie R, Kraemer A, Padilla O, Chiang V, Faramand AM, Palmer JD, Zacharia BE, Wegner RE, Hattangadi-Gluth JA, Levy A, Bernstein K, Mathieu D, Cagney DN, Chan MD, Grills IS, Braunstein S, Lee CC, Sheehan JP, Kluwe C, Patel S, Halasz LM, Andratschke N, Deibert CP, Verma V, Trifiletti DM, Cifarelli CP, Debus J, Combs SE, Sato Y, Higuchi Y, Aoyagi K, Brown PD, Alami V, Niranjan A, Lunsford LD, Kondziolka D, Camidge DR, Kavanagh BD, Robin TP, Serizawa T, Yamamoto M. Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE). J Natl Cancer Inst. 2023 Aug 8;115(8):926-936. PubMed PMID: 37142267
• Langston J, Patil T, Ross Camidge D, Bunn PA, Schenk EL, Pacheco JM, Jurica J, Waxweiler TV, Kavanagh BD, Rusthoven CG. CNS Downstaging: An Emerging Treatment Paradigm for Extensive Brain Metastases in Oncogene-Addicted Lung Cancer. Lung Cancer. 2023 Apr;178:103-107. PubMed PMID: 36809719
• Miller R, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Lu B, Werner-Wasik M, Ghassemi N, Lombardo J, Barta J, Grills I, Rusthoven CG, Guerrero T, Vinogradskiy Y. Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial. Adv Radiat Oncol. 2023 Mar-Apr;8(2):101133. PubMed PMID: 36618762
• Jeans EB, Brower JV, Burmeister JW, Deville C Jr, Fields E, Kavanagh BD, Suh JH, Tekian A, Vapiwala N, Zeman EM, Golden DW. Development of a United States Radiation Oncology Curricular Framework: A Stakeholder Delphi Consensus. Int J Radiat Oncol Biol Phys. 2023 Apr 1;115(5):1030-1040. PubMed PMID: 36549345
• Milano MT, Soltys SG, Marks LB, Heron DE, Yorke E, Grimm J, Jackson A, Mihai A, Timmerman RD, Xue J, Kavanagh BD, Redmond KJ. The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):294-296. PubMed PMID: 36400622
• Miller R, Castillo R, Castillo E, Jones BL, Miften M, Kavanagh B, Lu B, Werner-Wasik M, Ghassemi N, Lombardo J, Barta J, Grills I, Rusthoven CG, Guerrero T, Vinogradskiy Y. Characterizing Pulmonary Function Test Changes for Patients With Lung Cancer Treated on a 2-Institution, 4-Dimensional Computed Tomography-Ventilation Functional Avoidance Prospective Clinical Trial. Adv Radiat Oncol. 2023 Mar-Apr;8(2):101133. PubMed PMID: 36618762
• Milano MT, Soltys SG, Marks LB, Heron DE, Yorke E, Grimm J, Jackson A, Mihai A, Timmerman RD, Xue J, Kavanagh BD, Redmond KJ. The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):294-296. PubMed PMID: 36400622
• Bayat F, Eldib ME, Kavanagh B, Miften M, Altunbas C. Concurrent kilovoltage CBCT imaging and megavoltage beam delivery: suppression of cross-scatter with 2D antiscatter grids and grid-based scatter sampling. Phys Med Biol. 2022 Aug 9;67(16). PubMed PMID: 35853441
• Liu J, Chen YJ, Williams TM, Fields E, Kavanagh B, Shah C, Royce T, Ladbury C, Amini A, Glaser S. Evaluation of Radiation Oncologist and Trainee Opinions on Residency Expansion, Possible Actions, and Training Program Accreditation Changes in the United States. Int J Radiat Oncol Biol Phys. 2022 Sep 1;114(1):16-20. PubMed PMID: 35595159
• Das IJ, Dawes SL, Dominello MM, Kavanagh B, Miyamoto CT, Pawlicki T, Santanam L, Vinogradskiy Y, Yeung AR. Quality and Safety Considerations in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: An ASTRO Safety White Paper Update. Pract Radiat Oncol. 2022 Jul-Aug;12(4):e253-e268. PubMed PMID: 35283342
• Alvi MA, Asher AL, Michalopoulos GD, Grills IS, Warnick RE, McInerney J, Chiang VL, Attia A, Timmerman R, Chang E, Kavanagh BD, Andrews DW, Walter K, Bydon M, Sheehan JP. Factors associated with progression and mortality among patients undergoing stereotactic radiosurgery for intracranial metastasis: results from a national real-world registry. J Neurosurg. 2022 Jan 14;:1-14. [Epub ahead of print] PubMed PMID: 35171833
• Vinogradskiy Y, Castillo R, Castillo E, Schubert L, Jones BL, Faught A, Gaspar LE, Kwak J, Bowles DW, Waxweiler T, Dougherty JM, Gao D, Stevens C, Miften M, Kavanagh B, Grills I, Rusthoven CG, Guerrero T. Results of a Multi-Institutional Phase 2 Clinical Trial for 4DCT-Ventilation Functional Avoidance Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022 Mar 15;112(4):986-995. PubMed PMID: 34767934
• Tsui DCC, Kavanagh BD, Honce JM, Rossi C, Patil T, Camidge DR. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib. Clin Lung Cancer. 2022 Jan;23(1):e5-e8. PubMed PMID: 34246540
• Jeans EB, Brower JV, Burmeister JW, Deville C Jr, Fields E, Kavanagh BD, Suh JH, Tekian A, Vapiwala N, Zeman EM, Golden DW. Development of a United States Radiation Oncology Curricular Framework: A Stakeholder Delphi Consensus. Int J Radiat Oncol Biol Phys. 2022 Dec 19. [Epub ahead of print] PubMed PMID: 36549345
• Tsui DCC, Kavanagh BD, Honce JM, Rossi C, Patil T, Camidge DR. Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib. Clin Lung Cancer. 2022 Jan;23(1):e5-e8. PubMed PMID: 34246540
• Grimm J, Jackson A, Kavanagh BD, Marks LB, Yorke E, Xue J. Editorial. Med Phys. 2021 Jun;48(6):2699-2700. PubMed PMID: 34235767
• Kavanagh BD. The Economics of Using Locally Ablative Therapy in Oligometastatic Cancer. Semin Radiat Oncol. 2021 Jul;31(3):250-252. PubMed PMID: 34090652
• Grimm J, Marks LB, Jackson A, Kavanagh BD, Xue J, Yorke E. High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):1-10. PubMed PMID: 33864823
• Goodman CR, Sim AJ, Jeans EB, Anderson JD, Dooley S, Agarwal A, Tye K, Albert A, Gillespie EF, Tendulkar RD, Fuller CD, Kavanagh BD, Campbell SR. No Longer a Match: Trends in Radiation Oncology National Resident Matching Program (NRMP) Data from 2010-2020 and Comparison Across Specialties. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):278-287. PubMed PMID: 33716120
• Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tomé WA, Ten Haken RK, Ohri N, Méndez Romero A, Goodman KA, Marks LB, Kavanagh B, Dawson LA. Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):196-205. PubMed PMID: 29482870
• Novak J, Cui Y, Frankel P, Sedrak MS, Glaser S, Li R, Motwani S, Kavanagh B, Amini A. Growth of the Social #RadOnc Network on Twitter. Pract Radiat Oncol. 2021 May-Jun;11(3):e263-e266. PubMed PMID: 32992029
• Boxley PJ, Smith DE, Gao D, Kessler ER, Echalier B, Bernard B, Ormond DR, Lam ET, Kavanagh BD, Flaig TW. Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort. Clin Genitourin Cancer. 2021 Jun;19(3):217-222.e1. PubMed PMID: 33069585
• Kavanagh BD. A Portrait of the Artist as a Younger Man. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):1122. PubMed PMID: 34793737
• Vinogradskiy Y, Castillo R, Castillo E, Schubert L, Jones BL, Faught A, Gaspar LE, Kwak J, Bowles DW, Waxweiler T, Dougherty JM, Gao D, Stevens C, Miften M, Kavanagh B, Grills I, Rusthoven CG, Guerrero T. Results of a Multi-institutional Phase 2 Clinical Trial for 4DCT-ventilation Functional Avoidance Thoracic Radiation Therapy. Int J Radiat Oncol Biol Phys. 2021 Nov 9. [Epub ahead of print] PubMed PMID: 34767934
• Hubbard A, Mantz C, Mohideen N, Hartsell W, Thaker NG, Orio P, Yashar C, Kavadi V, Kavanagh B, Adler D. Radiation Oncology's Place in Payment Reform: ASTRO Advocates for a Place at the Table. JCO Oncol Pract. 2021 Dec;17(12):777-781. PubMed PMID: 34524836
• Fields EC, Kavanagh BD. Navigating Past the Chaos of the Radiation Oncology 2021 Match. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):328-330. PubMed PMID: 34473972
• Fleming JL, Pugh S, Bell EH, Chang SM, McElroy J, Becker A, Timmers CD, Shih HA, Ashby L, Hunter GK, Bahary JP, Schultz CJ, Kavanagh BD, Yung WA, Robins I, Werner-Wasik M, Chakravarti A. Prognostic Significance of IDH1/2 Mutation and MGMT Promoter Methylation Status in RTOG 9813. Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1399. PubMed PMID: 33427658
• Boxley PJ, Smith DE, Gao D, Kessler ER, Echalier B, Bernard B, Ormond DR, Lam ET, Kavanagh BD, Flaig TW. Prostate Cancer Central Nervous System Metastasis in a Contemporary Cohort. Clin Genitourin Cancer. 2020 Aug 22. [Epub ahead of print] PubMed PMID: 33069585
• Novak J, Cui Y, Frankel P, Sedrak MS, Glaser S, Li R, Motwani S, Kavanagh B, Amini A. Growth of the Social #RadOnc Network on Twitter. Pract Radiat Oncol. 2020 Sep 28. [Epub ahead of print] PubMed PMID: 32992029
• Kavanagh BD, Doke K. The Virtual Visiting Professor: A Step Toward a Parasocial Common Curriculum?. Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):466-469. PubMed PMID: 32890534
• Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):631-640. PubMed PMID: 32589990
• Thomas DH, Schubert LK, Vinogradskiy Y, Nath S, Kavanagh B, Miften M, Jones B. Technical Note: Deep Learning approach for automatic detection and identification of patient positioning devices for radiation therapy. Med Phys. 2020 Oct;47(10):5061-5069. PubMed PMID: 32562501
• Rusthoven CG, Yamamoto M, Bernhardt D, Smith DE, Gao D, Serizawa T, Yomo S, Aiyama H, Higuchi Y, Shuto T, Akabane A, Sato Y, Niranjan A, Faramand AM, Lunsford LD, McInerney J, Tuanquin LC, Zacharia BE, Chiang V, Singh C, Yu JB, Braunstein S, Mathieu D, Touchette CJ, Lee CC, Yang HC, Aizer AA, Cagney DN, Chan MD, Kondziolka D, Bernstein K, Silverman JS, Grills IS, Siddiqui ZA, Yuan JC, Sheehan JP, Cordeiro D, Nosaki K, Seto T, Deibert CP, Verma V, Day S, Halasz LM, Warnick RE, Trifiletti DM, Palmer JD, Attia A, Li B, Cifarelli CP, Brown PD, Vargo JA, Combs SE, Kessel KA, Rieken S, Patel S, Guckenberger M, Andratschke N, Kavanagh BD, Robin TP. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study. JAMA Oncol. 2020 Jul 1;6(7):1028-1037. PubMed PMID: 32496550
• Guckenberger M, Belka C, Bezjak A, Bradley J, Daly ME, DeRuysscher D, Dziadziuszko R, Faivre-Finn C, Flentje M, Gore E, Higgins KA, Iyengar P, Kavanagh BD, Kumar S, Le Pechoux C, Lievens Y, Lindberg K, McDonald F, Ramella S, Rengan R, Ricardi U, Rimner A, Rodrigues GB, Schild SE, Senan S, Simone CB 2nd, Slotman BJ, Stuschke M, Videtic G, Widder J, Yom SS, Palma D. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020 May;146:223-229. PubMed PMID: 32342863
• Vinogradskiy Y, Diot Q, Jones B, Castillo R, Castillo E, Kwak J, Bowles D, Grills I, Myziuk N, Guerrero T, Stevens C, Schefter T, Gaspar LE, Kavanagh B, Miften M, Rusthoven C. Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer. Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1063-1070. PubMed PMID: 31983558
• Thomas DH, Miller B, Rabinovitch R, Milgrom S, Kavanagh B, Diot Q, Miften M, Schubert LK. Integration of automation into an existing clinical workflow to improve efficiency and reduce errors in the manual treatment planning process for total body irradiation (TBI). J Appl Clin Med Phys. 2020 Jul;21(7):100-106. PubMed PMID: 32426947
• Behbahani RA, Diot Q, Kavanagh B, Serkova NJ, Miften M, Westerly DC. Electromagnetic wave propagation in a fast pulse line ion accelerator. Med Phys. 2019 Dec;46(12):5714-5721. PubMed PMID: 31622500
• Altunbas C, Alexeev T, Miften M, Kavanagh B. Effect of grid geometry on the transmission properties of 2D grids for flat detectors in CBCT. Phys Med Biol. 2019 Nov 15;64(22):225006. PubMed PMID: 31585444
• Kavanagh B. Radiation Oncology APM: Why Us? Why Now?. Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):22-24. PubMed PMID: 31422809
• Siker M, Kavanagh BD. Halfway Toward Half Full. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):997-998. PubMed PMID: 31327431
• Mohideen N, Kavanagh BD. Model Insurance Coverage Policies: The Power of Suggestion, the Force of Evidence. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):745-747. PubMed PMID: 31204660
• Ladbury CJ, Rusthoven CG, Camidge DR, Kavanagh BD, Nath SK. Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):346-355. PubMed PMID: 31175902
• Gomez DR, Tang C, Zhang J, Blumenschein GR Jr, Hernandez M, Lee JJ, Ye R, Palma DA, Louie AV, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Welsh JW, Gibbons DL, Karam JA, Kavanagh BD, Tsao AS, Sepesi B, Swisher SG, Heymach JV. Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study. J Clin Oncol. 2019 Jun 20;37(18):1558-1565. PubMed PMID: 31067138
• Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clin Cancer Res. 2019 Jul 1;25(13):3946-3953. PubMed PMID: 30940654
• Pacheco JM, Gao D, Smith D, Purcell T, Hancock M, Bunn P, Robin T, Liu A, Karam S, Gaspar L, Kavanagh B, Rusthoven C, Aisner D, Doebele R, Camidge DR. Natural History and Factors Associated with Overall Survival in Stage IV ALK-Rearranged Non-Small Cell Lung Cancer. J Thorac Oncol. 2019 Apr;14(4):691-700. PubMed PMID: 30599201
• Vinogradskiy Y, Rusthoven CG, Schubert L, Jones B, Faught A, Castillo R, Castillo E, Gaspar LE, Kwak J, Waxweiler T, Dougherty M, Gao D, Stevens C, Miften M, Kavanagh B, Guerrero T, Grills I. Interim Analysis of a Two-Institution, Prospective Clinical Trial of 4DCT-Ventilation-based Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1357-1365. PubMed PMID: 30353873
• Knoll MA, Kavanagh B, Katz M. The 2017 American Society of Radiation Oncology (ASTRO) annual meeting: Taking a deeper dive into social media. Adv Radiat Oncol. 2018 Jul-Sep;3(3):230-233. PubMed PMID: 30197934
• Robin TP, Breeze RE, Smith DE, Rusthoven CG, Lewis KD, Gonzalez R, Brill A, Saiki R, Stuhr K, Gaspar LE, Karam SD, Raben D, Kavanagh BD, Nath SK, Liu AK. Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases. J Neurooncol. 2018 Oct;140(1):55-62. PubMed PMID: 29909499
• Westerly DC, Behbahani RA, Kavanagh B, Liu A, Miften M, Serkova NJ, Diot Q. Design considerations for a pulse line ion accelerator (PLIA)-based PET isotope generator. Med Phys. 2018 Jun 15. [Epub ahead of print] PubMed PMID: 29905959
• Robin TP, Jones BL, Amini A, Koshy M, Gaspar LE, Liu AK, Nath SK, Kavanagh BD, Camidge DR, Rusthoven CG. Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer. Lung Cancer. 2018 Jun;120:88-90. PubMed PMID: 29748022
• Kavanagh BD. Honor Was Never Lost: The National Farm Machinery Show and the American Society for Radiation Oncology Annual Meeting. Int J Radiat Oncol Biol Phys. 2018 Jun 1;101(2):259-260. PubMed PMID: 29726350
• Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tomé WA, Ten Haken RK, Ohri N, Méndez Romero A, Goodman KA, Marks LB, Kavanagh B, Dawson LA. Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys. 2018 Jan 6. [Epub ahead of print] PubMed PMID: 29482870
• Rusthoven CG, Jones BL, Kavanagh BD. Medical operability and inoperability drive survival in retrospective analyses comparing surgery and SBRT for early-stage lung cancer. J Thorac Cardiovasc Surg. 2018 Feb;155(2):810-811. PubMed PMID: 29415393
• Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, Sher DJ, Louie AV, Palma DA, Senan S, Gaspar LE, Kavanagh BD, Rusthoven CG. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 Mar 1;36(7):642-651. PubMed PMID: 29346041
• Robin TP, Camidge DR, Stuhr K, Nath SK, Breeze RE, Pacheco JM, Liu AK, Gaspar LE, Purcell WT, Doebele RC, Kavanagh BD, Rusthoven CG. Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in ALK and EGFR Driven Non-Small Cell Lung Cancer. J Thorac Oncol. 2018 May;13(5):715-720. PubMed PMID: 29269007
• Alexeev T, Kavanagh B, Miften M, Altunbas C. Two-dimensional antiscatter grid: A novel scatter rejection device for Cone-beam computed tomography. Med Phys. 2018 Feb;45(2):529-534. PubMed PMID: 29235120
• Sheehan J, Suh JH, Kavanagh B, Xu Z, Ren L, Sheehan K, Lunsford LD. Training Neurosurgery and Radiation Oncology Residents in Stereotactic Radiosurgery: Assessment Gathered from Participants in AANS and ASTRO Training Course. World Neurosurg. 2018 Jan;109:e669-e675. PubMed PMID: 29061451
• Chen AB, Li L, Cronin AM, Brooks GA, Kavanagh BD, Schrag D. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?. Health Serv Res. 2018 Aug;53 Suppl 1:3227-3244. PubMed PMID: 28858372
• Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2018 May;41(5):476-484. PubMed PMID: 27281264
• Sheehan J, Suh JH, Kavanagh B, Xu Z, Ren L, Sheehan K, Lunsford LD. Training Neurosurgery and Radiation Oncology Residents in Stereotactic Radiosurgery: Assessment Gathered from Participants in AANS and ASTRO Training Course. World Neurosurg. 2018 Jan;109:e669-e675. PubMed PMID: 29061451
• Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, Sher DJ, Louie AV, Palma DA, Senan S, Gaspar LE, Kavanagh BD, Rusthoven CG. Post-Treatment Mortality After Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2018 Jan 18;:JCO2017756536. [Epub ahead of print] PubMed PMID: 29346041
• Robin TP, Camidge DR, Stuhr K, Nath SK, Breeze RE, Pacheco J, Liu AK, Gaspar LE, Purcell WT, Doebele RC, Kavanagh BD, Rusthoven CG. Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in Oncogene-Addicted Non-Small-Cell Lung Cancer. J Thorac Oncol. 2017 Dec 18. [Epub ahead of print] PubMed PMID: 29269007
• Alexeev T, Kavanagh B, Miften M, Altunbas C. Two-dimensional antiscatter grid: A novel scatter rejection device for Cone-beam computed tomography. Med Phys. 2017 Dec 12. [Epub ahead of print] PubMed PMID: 29235120
• Jaffee EM, Dang CV, Agus DB, Alexander BM, Anderson KC, Ashworth A, Barker AD, Bastani R, Bhatia S, Bluestone JA, Brawley O, Butte AJ, Coit DG, Davidson NE, Davis M, DePinho RA, Diasio RB, Draetta G, Frazier AL, Futreal A, Gambhir SS, Ganz PA, Garraway L, Gerson S, Gupta S, Heath J, Hoffman RI, Hudis C, Hughes-Halbert C, Ibrahim R, Jadvar H, Kavanagh B, Kittles R, Le QT, Lippman SM, Mankoff D, Mardis ER, Mayer DK, McMasters K, Meropol NJ, Mitchell B, Naredi P, Ornish D, Pawlik TM, Peppercorn J, Pomper MG, Raghavan D, Ritchie C, Schwarz SW, Sullivan R, Wahl R, Wolchok JD, Wong SL, Yung A. Future cancer research priorities in the USA: a Lancet Oncology Commission. Lancet Oncol. 2017 Nov;18(11):e653-e706. PubMed PMID: 29208398
• Sumner WA, Amini A, Hankinson TC, Foreman NK, Gaspar LE, Kavanagh BD, Karam SD, Rusthoven CG, Liu AK. Survival benefit of postoperative radiation in papillary meningioma: Analysis of the National Cancer Data Base. Rep Pract Oncol Radiother. 2017 Nov-Dec;22(6):495-501. PubMed PMID: 29123457
• Rusthoven CG, Kavanagh BD. Prophylactic Cranial Irradiation (PCI) versus Active MRI Surveillance for Small Cell Lung Cancer: The Case for Equipoise. J Thorac Oncol. 2017 Dec;12(12):1746-1754. PubMed PMID: 28882584
• Trifiletti DM, Sheehan JP, Grover S, Dutta SW, Rusthoven CG, Kavanagh BD, Sahgal A, Showalter TN. National trends in radiotherapy for brain metastases at time of diagnosis of non-small cell lung cancer. J Clin Neurosci. 2017 Nov;45:48-53. PubMed PMID: 28866073
• Chen AB, Li L, Cronin AM, Brooks GA, Kavanagh BD, Schrag D. Estimating Costs of Care Attributable to Cancer: Does the Choice of Comparison Group Matter?. Health Serv Res. 2017 Aug 31. [Epub ahead of print] PubMed PMID: 28858372
• Yang X, Su LJ, La Rosa FG, Smith EE, Schlaepfer IR, Cho SK, Kavanagh B, Park W, Flaig TW. The Antineoplastic Activity of Photothermal Ablative Therapy with Targeted Gold Nanorods in an Orthotopic Urinary Bladder Cancer Model. Bladder Cancer. 2017 Jul 27;3(3):201-210. PubMed PMID: 28824948
• Rusthoven CG, Kavanagh BD. Prophylactic cranial irradiation in small-cell lung cancer. Lancet Oncol. 2017 Jul;18(7):e365. PubMed PMID: 28677568
• Stokes WA, Kavanagh BD, Raben D, Pugh TJ. Implementation of hypofractionated prostate radiation therapy in the United States: A National Cancer Database analysis. Pract Radiat Oncol. 2017 Jul - Aug;7(4):270-278. PubMed PMID: 28673554
• Goodman KA, Kavanagh BD. Stereotactic Body Radiotherapy for Liver Metastases. Semin Radiat Oncol. 2017 Jul;27(3):240-246. PubMed PMID: 28577831
• Altunbas C, Kavanagh B, Alexeev T, Miften M. Transmission characteristics of a two dimensional antiscatter grid prototype for CBCT. Med Phys. 2017 Aug;44(8):3952-3964. PubMed PMID: 28513847
• Jackson MW, Amini A, Jones BL, Kavanagh B, Maroni P, Frank SJ, Mahmood U, Kudchadker RJ, Pugh TJ. Prostate brachytherapy, either alone or in combination with external beam radiation, is associated with longer overall survival in men with favorable pathologic Group 4 (Gleason score 8) prostate cancer. Brachytherapy. 2017 Jul - Aug;16(4):790-796. PubMed PMID: 28442277
• Waxweiler T, Schubert L, Diot Q, Faught A, Stuhr K, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M, Vinogradskiy Y. A complete 4DCT-ventilation functional avoidance virtual trial: Developing strategies for prospective clinical trials. J Appl Clin Med Phys. 2017 May;18(3):144-152. PubMed PMID: 28436107
• Rusthoven CG, Palma DA, Senan S, Kavanagh BD. The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non-Small-Cell Lung Cancer?. J Clin Oncol. 2017 May 20;35(15):1749-1751. PubMed PMID: 28221860
• Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 Apr;12(4):734-744. PubMed PMID: 28126540
• Magnuson WJ, Lester-Coll NH, Wu AJ, Yang TJ, Lockney NA, Gerber NK, Beal K, Amini A, Patil T, Kavanagh BD, Camidge DR, Braunstein SE, Boreta LC, Balasubramanian SK, Ahluwalia MS, Rana NG, Attia A, Gettinger SN, Contessa JN, Yu JB, Chiang VL. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis. J Clin Oncol. 2017 Apr 1;35(10):1070-1077. PubMed PMID: 28113019
• Vinogradskiy Y, Jackson M, Schubert L, Jones B, Castillo R, Castillo E, Guerrero T, Mitchell J, Rusthoven C, Miften M, Kavanagh B. Assessing the use of 4DCT-ventilation in pre-operative surgical lung cancer evaluation. Med Phys. 2017 Jan;44(1):200-208. PubMed PMID: 28102961
• Rusthoven CG, Jones BL, Kavanagh BD, Pugh TJ. Reply to J.B. Aragon-Ching and D. Dalela et al. J Clin Oncol. 2017 Mar 10;35(8):916-917. PubMed PMID: 27937090
• Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Pract Radiat Oncol. 2017 Jan - Feb;7(1):e43-e49. PubMed PMID: 27637137
• Kim DN, Straka C, Cho LC, Lotan Y, Yan J, Kavanagh B, Raben D, Cooley S, Brindle J, Xie XJ, Pistenmaa D, Timmerman R. Early and multiple PSA bounces can occur following high-dose prostate stereotactic body radiation therapy: Subset analysis of a phase 1/2 trial. Pract Radiat Oncol. 2017 Jan - Feb;7(1):e43-e49. PubMed PMID: 27637137
• Kavanagh BD. From the Guest Editor: New Lenses, New Visions for Radiotherapy in the Molecular-Genetic-Immunomodulator Era of Oncology. Cancer J. 2016 Jul-Aug;22(4):245-6. PubMed PMID: 27441743
• Vinogradskiy Y, Schubert L, Diot Q, Waxweiller T, Koo P, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M. Regional Lung Function Profiles of Stage I and III Lung Cancer Patients: An Evaluation for Functional Avoidance Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Jul 15;95(4):1273-80. PubMed PMID: 27354134
• Rusthoven CG, Jones BL, Flaig TW, Crawford ED, Koshy M, Sher DJ, Mahmood U, Chen RC, Chapin BF, Kavanagh BD, Pugh TJ. Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer. J Clin Oncol. 2016 Aug 20;34(24):2835-42. PubMed PMID: 27325855
• Zhao J, Yorke ED, Li L, Kavanagh BD, Li XA, Das S, Miften M, Rimner A, Campbell J, Xue J, Jackson A, Grimm J, Milano MT, Spring Kong FM. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1357-66. PubMed PMID: 27325482
• Benedict SH, Hoffman K, Martel MK, Abernethy AP, Asher AL, Capala J, Chen RC, Chera B, Couch J, Deye J, Efstathiou JA, Ford E, Fraass BA, Gabriel PE, Huser V, Kavanagh BD, Khuntia D, Marks LB, Mayo C, McNutt T, Miller RS, Moore KL, Prior F, Roelofs E, Rosenstein BS, Sloan J, Theriault A, Vikram B. Overview of the American Society for Radiation Oncology-National Institutes of Health-American Association of Physicists in Medicine Workshop 2015: Exploring Opportunities for Radiation Oncology in the Era of Big Data. Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):873-9. PubMed PMID: 27302503
• Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2016 Jun 8. [Epub ahead of print] PubMed PMID: 27281264
• Rusthoven CG, Koshy M, Sher DJ, Ney DE, Gaspar LE, Jones BL, Karam SD, Amini A, Ormond DR, Youssef AS, Kavanagh BD. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis. JAMA Neurol. 2016 Jul 1;73(7):821-8. PubMed PMID: 27214765
• Amini A, Jones BL, Yeh N, Guntupalli SR, Kavanagh BD, Karam SD, Fisher CM. Disparities in disease presentation in the four screenable cancers according to health insurance status. Public Health. 2016 Sep;138:50-6. PubMed PMID: 27091437
• Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, Raben D, Nanda A, Cooley S, Kim DW, Pistenmaa D, Lotan Y, Timmerman R. Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial. Eur J Cancer. 2016 May;59:142-51. PubMed PMID: 27035363
• Amini A, Kavanagh BD, Rusthoven CG. Improved survival with the addition of radiotherapy to androgen deprivation: questions answered and a review of current controversies in radiotherapy for non-metastatic prostate cancer. Ann Transl Med. 2016 Jan;4(1):14. PubMed PMID: 26855950
• Amini A, Jones BL, Jackson MW, Rusthoven CG, Maroni P, Kavanagh BD, Raben D. Survival outcomes of combined external beam radiotherapy and brachytherapy vs. brachytherapy alone for intermediate-risk prostate cancer patients using the National Cancer Data Base. Brachytherapy. 2016 Mar-Apr;15(2):136-46. PubMed PMID: 26825856
• Chen RC, Gabriel PE, Kavanagh BD, McNutt TR. How Will Big Data Impact Clinical Decision Making and Precision Medicine in Radiation Therapy?. Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):880-4. PubMed PMID: 26797536
• Amini A, Rusthoven CG, Jones BL, Armstrong H, Raben D, Kavanagh BD. Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base. Urol Oncol. 2016 Apr;34(4):165.e1-9. PubMed PMID: 26699831
• Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2016 May;195(5):1453-8. PubMed PMID: 26576709
• Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. J Clin Oncol. 2016 Jan 10;34(2):123-9. PubMed PMID: 26438117
• Sheehan JP, Kavanagh BD, Asher A, Harbaugh RE. Inception of a national multidisciplinary registry for stereotactic radiosurgery. J Neurosurg. 2016 Jan;124(1):155-62. PubMed PMID: 26252466
• Vinogradskiy Y, Jackson M, Schubert L, Jones B, Castillo R, Castillo E, Guerrero T, Mitchell J, Kavanagh B, Miften M. WE-AB-BRA-06: 4DCT-Ventilation: A Novel Imaging Modality for Thoracic Surgical Evaluation. Med Phys. 2016 Jun;43(6):3792. PubMed PMID: 28048542
• Altunbas C, Kavanagh B, Miften M. WE-AB-207A-10: Transmission Characteristics of a Two Dimensional Antiscatter Grid Prototype for CBCT. Med Phys. 2016 Jun;43(6):3799-3800. PubMed PMID: 28046458
• Rusthoven CG, Jones BL, Kavanagh BD, Pugh TJ. Reply to J.B. Aragon-Ching and D. Dalela et al. J Clin Oncol. 2016 Dec 12;:JCO2016709220. [Epub ahead of print] PubMed PMID: 27937090
• Gomez DR, Blumenschein GR Jr, Lee JJ, Hernandez M, Ye R, Camidge DR, Doebele RC, Skoulidis F, Gaspar LE, Gibbons DL, Karam JA, Kavanagh BD, Tang C, Komaki R, Louie AV, Palma DA, Tsao AS, Sepesi B, William WN, Zhang J, Shi Q, Wang XS, Swisher SG, Heymach JV. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016 Dec;17(12):1672-1682. PubMed PMID: 27789196
• Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. J Clin Oncol. 2016 Jan 10;34(2):123-9. PubMed PMID: 26438117
• Sheehan JP, Kavanagh BD, Asher A, Harbaugh RE. Inception of a national multidisciplinary registry for stereotactic radiosurgery. J Neurosurg. 2016 Jan;124(1):155-62. PubMed PMID: 26252466
• Rusthoven CG, Kavanagh BD, Karam SD. Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data. Ann Transl Med. 2015 Jul;3(11):149. PubMed PMID: 26244136
• Soltys SG, Kirkpatrick JP, Laack NN, Kavanagh BD, Breneman JC, Shih HA. Is Less, More? The Evolving Role of Radiation Therapy for Brain Metastases. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):963-6. PubMed PMID: 26194672
• Haffty BG, Beyer DC, Kavanagh BD. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer. JAMA Dermatol. 2015 Sep;151(9):1036. PubMed PMID: 26177072
• Amini A, Altoos B, Bourlon MT, Bedrick E, Bhatia S, Kessler ER, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?. Pract Radiat Oncol. 2015 Nov-Dec;5(6):e589-96. PubMed PMID: 26142027
• Carlson JA, Reddy K, Gaspar LE, Ney D, Kavanagh BD, Damek D, Lillehei K, Chen C. Hypofractionated-intensity modulated radiotherapy (hypo-IMRT) and temozolomide (TMZ) with or without bevacizumab (BEV) for newly diagnosed glioblastoma multiforme (GBM): a comparison of two prospective phase II trials. J Neurooncol. 2015 Jun;123(2):251-7. PubMed PMID: 25920710
• Rusthoven CG, Carlson JA, Kavanagh BD. External Validation of the Benefit of Adjuvant Radiotherapy for Pathologic N1M0 Prostate Cancer. J Clin Oncol. 2015 Jun 10;33(17):1987-8. PubMed PMID: 25847937
• Brennan D, Schubert L, Diot Q, Castillo R, Castillo E, Guerrero T, Martel MK, Linderman D, Gaspar LE, Miften M, Kavanagh BD, Vinogradskiy Y. Clinical validation of 4-dimensional computed tomography ventilation with pulmonary function test data. Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):423-9. PubMed PMID: 25817531
• Rusthoven CG, Kavanagh BD. Considerations for observational research: in regard to Jagsi et al. Int J Radiat Oncol Biol Phys. 2015 Mar 1;91(3):679-80. PubMed PMID: 25680608
• Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2015 Mar;122(1):135-43. PubMed PMID: 25524817
• Rusthoven CG, Waxweiler TV, DeWitt PE, Flaig TW, Raben D, Kavanagh BD. Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer. Urol Oncol. 2015 Feb;33(2):71.e11-9. PubMed PMID: 25151595
• Chen RC, Gabriel PE, Kavanagh BD, McNutt TR. How Will Big Data Impact Clinical Decision Making and Precision Medicine in Radiation Therapy?. Int J Radiat Oncol Biol Phys. 2015 Nov 6. [Epub ahead of print] PubMed PMID: 26797536
• Amini A, Rusthoven CG, Jones BL, Armstrong H, Raben D, Kavanagh BD. Survival outcomes of radiotherapy with or without androgen-deprivation therapy for patients with intermediate-risk prostate cancer using the National Cancer Data Base. Urol Oncol. 2015 Dec 11. [Epub ahead of print] PubMed PMID: 26699831
• Amini A, Jones BL, Yeh N, Rusthoven CG, Armstrong H, Kavanagh BD. Survival Outcomes of Whole-Pelvic Versus Prostate-Only Radiation Therapy for High-Risk Prostate Cancer Patients With Use of the National Cancer Data Base. Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):1052-63. PubMed PMID: 26581142
• Amini A, Jones B, Jackson MW, Yeh N, Waxweiler TV, Maroni P, Kavanagh BD, Raben D. Survival Outcomes of Dose-Escalated External Beam Radiotherapy (DE-EBRT) Versus Combined Brachytherapy for Intermediate- and High-Risk Prostate Cancer Using the National Cancer Data Base. J Urol. 2015 Nov 11. [Epub ahead of print] PubMed PMID: 26576709
• Diot Q, Kavanagh B, Vinogradskiy Y, Garg K, Gaspar L, Miften M. Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy. Med Phys. 2015 Nov;42(11):6477-87. PubMed PMID: 26520737
• Altoos B, Amini A, Yacoub M, Bourlon MT, Kessler EE, Flaig TW, Fisher CM, Kavanagh BD, Lam ET, Karam SD. Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to Thoracic, Abdominal, and Soft Tissue Lesions Using Stereotactic Body Radiotherapy (SBRT). Radiat Oncol. 2015 Oct 28;10:218. PubMed PMID: 26510665
• Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RA, Timmerman RD, Wong JW. Technology for Innovation in Radiation Oncology. Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):485-92. PubMed PMID: 26460989
• Rusthoven CG, Carlson JA, Waxweiler TV, Yeh N, Raben D, Flaig TW, Kavanagh BD. The prognostic significance of Gleason scores in metastatic prostate cancer. Urol Oncol. 2014 Mar 11. [Epub ahead of print] PubMed PMID: 24629494
• Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, Kavanagh B, Kabos P. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol. 2014 Feb 3. [Epub ahead of print] PubMed PMID: 24497407
• Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients Receiving Crizotinib. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):892-8. PubMed PMID: 24462383
• Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Barón AE, Yeh N, Gaspar LE, Liu AK, Ney DE, Damek DM, Lillehei KO, Kavanagh BD. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):894-902. PubMed PMID: 25585784
• Bourlon MT, Amini A, Kavanagh BD, Flaig TW. Pancreatic metastases from renal cell carcinoma treated with stereotactic body radiation therapy. Oncology (Williston Park). 2014 Nov 7;28(11). PubMed PMID: 25560737
• Ney DE, Carlson JA, Damek DM, Gaspar LE, Kavanagh BD, Kleinschmidt-DeMasters BK, Waziri AE, Lillehei KO, Reddy K, Chen C. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma. J Neurooncol. 2014 Dec 19. [Epub ahead of print] PubMed PMID: 25524817
• Hahn C, Kavanagh B, Bhatnagar A, Jacobson G, Lutz S, Patton C, Potters L, Steinberg M. Choosing wisely: the American Society for Radiation Oncology's top 5 list. Pract Radiat Oncol. 2014;4(6):349-55. PubMed PMID: 25407853
• Iyengar P, Kavanagh BD, Wardak Z, Smith I, Ahn C, Gerber DE, Dowell J, Hughes R, Abdulrahman R, Camidge DR, Gaspar LE, Doebele RC, Bunn PA, Choy H, Timmerman R. Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. J Clin Oncol. 2014 Dec 1;32(34):3824-30. PubMed PMID: 25349291
• Amini A, Yeh N, Gaspar LE, Kavanagh B, Karam SD. Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review. Radiat Oncol. 2014 Sep 19;9:210. PubMed PMID: 25239200
• Rusthoven CG, Waxweiler TV, DeWitt PE, Flaig TW, Raben D, Kavanagh BD. Gleason stratifications prognostic for survival in men receiving definitive external beam radiation therapy for localized prostate cancer. Urol Oncol. 2014 Aug 20. [Epub ahead of print] PubMed PMID: 25151595
• Kavanagh BD, Haffty BG, Tepper JE. Radiation oncology: a snapshot in time, 2014. J Clin Oncol. 2014 Sep 10;32(26):2825-6. PubMed PMID: 25113774
• Kavanagh BD. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes. J Clin Oncol. 2014 Sep 10;32(26):2827-31. PubMed PMID: 25113758
• Altunbas C, Howells C, Proper M, Reddy K, Gan G, DeWitt P, Kavanagh B, Schefter T, Miften M. Evaluation of threshold and gradient based (18)F-fluoro-deoxy-2-glucose hybrid positron emission tomographic image segmentation methods for liver tumor delineation. Pract Radiat Oncol. 2014 Jul-Aug;4(4):217-25. PubMed PMID: 25012829
• Reddy K, Gaspar LE, Kavanagh BD, Chen C. Hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy may alter the patterns of failure in patients with glioblastoma multiforme. J Med Imaging Radiat Oncol. 2014 Dec;58(6):714-21. PubMed PMID: 24975917
• Diot Q, Marks LB, Bentzen SM, Senan S, Kavanagh BD, Lawrence MV, Miften M, Palma DA. Comparison of radiation-induced normal lung tissue density changes for patients from multiple institutions receiving conventional or hypofractionated treatments. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):626-32. PubMed PMID: 24929168
• Kim DW, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kueplian P, Brindle J, Cooley S, Perkins A, Raben D, Xie XJ, Timmerman RD. Predictors of rectal tolerance observed in a dose-escalated phase 1-2 trial of stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):509-17. PubMed PMID: 24929162
• Mohideen N, Kavanagh BD, Beyer D, Madhani S, Steinberg ML. Radiation oncology: a perspective on health reform and value-based initiatives. J Oncol Pract. 2014 Jul;10(4):e212-4. PubMed PMID: 24893609
• Vinogradskiy Y, Koo PJ, Castillo R, Castillo E, Guerrero T, Gaspar LE, Miften M, Kavanagh BD. Comparison of 4-dimensional computed tomography ventilation with nuclear medicine ventilation-perfusion imaging: a clinical validation study. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):199-205. PubMed PMID: 24725702
• Rusthoven CG, Carlson JA, Waxweiler TV, Raben D, Dewitt PE, Crawford ED, Maroni PD, Kavanagh BD. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1064-73. PubMed PMID: 24661660
• Rusthoven CG, Carlson JA, Waxweiler TV, Yeh N, Raben D, Flaig TW, Kavanagh BD. The prognostic significance of Gleason scores in metastatic prostate cancer. Urol Oncol. 2014 Jul;32(5):707-13. PubMed PMID: 24629494
• Carlson JA, Nooruddin Z, Rusthoven C, Elias A, Borges VF, Diamond JR, Kavanagh B, Kabos P. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema. Neuro Oncol. 2014 Jul;16(7):1006-9. PubMed PMID: 24497407
• Gan GN, Weickhardt AJ, Scheier B, Doebele RC, Gaspar LE, Kavanagh BD, Camidge DR. Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib. Int J Radiat Oncol Biol Phys. 2014 Mar 15;88(4):892-8. PubMed PMID: 24462383
• Kavanagh BD, Rabinovitch R, Mohideen N. Improved cosmesis in early breast cancer using conformal radiotherapy. J Clin Oncol. 2013 Dec 20;31(36):4483-4. PubMed PMID: 24248685
• Jones BL, Gan G, Kavanagh B, Miften M. Effect of endorectal balloon positioning errors on target deformation and dosimetric quality during prostate SBRT. Phys Med Biol. 2013 Nov 21;58(22):7995-8006. PubMed PMID: 24169860
• Altunbas C, Kavanagh B, Dzingle W, Stuhr K, Gaspar L, Miften M. Dosimetric errors during treatment of centrally located lung tumors with stereotactic body radiation therapy: Monte Carlo evaluation of tissue inhomogeneity corrections. Med Dosim. 2013 Winter;38(4):436-41. PubMed PMID: 24119416
• Vinogradskiy Y, Diot Q, Kavanagh B, Schefter T, Gaspar L, Miften M. Spatial and dose-response analysis of fibrotic lung changes after stereotactic body radiation therapy. Med Phys. 2013 Aug;40(8):081712. PubMed PMID: 23927309
• Gibbs IC, Haas-Kogan D, Terezakis S, Kavanagh BD. The subventricular zone neural progenitor cell hypothesis in glioblastoma: epiphany, Trojan Horse, or Cheshire fact?. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):606-8. PubMed PMID: 23773389
• Reddy K, Gaspar LE, Kavanagh BD, Waziri A, Damek DM, Ney D, Lillehei KO, Chen C. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol. 2013 Aug;114(1):111-6. PubMed PMID: 23729276
• Amin NP, Miften M, Thornton D, Ryan N, Kavanagh B, Gaspar LE. Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer. Med Dosim. 2013 Autumn;38(3):320-6. PubMed PMID: 23611631
• Cho LC, Timmerman R, Kavanagh B. Hypofractionated external-beam radiotherapy for prostate cancer. Prostate Cancer. 2013;2013:103547. PubMed PMID: 23533777
• Cho LC, Timmerman RD, Kavanagh B. Hypofractionated External-Beam Radiotherapy for Prostate Cancer. Prostate Cancer, vol. 2013, Article ID 103547, 11 pages, 2013. doi:10.1155/2013/103547
• Gibbs I, Haas-Kogan D; Terezakis S, Kavanagh B. The subventricular zone neural progenitor cell hypothesis in glioblastoma: Epiphany, Trojan Horse, or Cheshire Fact? Int J Radiat Oncol Biol Phys, in press, 2013
• Solberg TD, Siddon RL, Kavanagh B. Historical Development of Stereotactic Ablative Radiotherapy. In Stereotactic Body Radiation Therapy; Lo S, Teh BS; Lu JJ; Schefter TE, eds. Springer, 2012.
• Amin N, Tracey E. Schefter TE, Okunieff P, Kavanagh B, Milano MT. Lung Metastasis. In Stereotactic Body Radiation Therapy; Lo S, Teh BS; Lu JJ; Schefter TE, eds. Springer, 2012.
• Stinauer M, Lanciano R, Schefter TE, Kavanagh B, Carlson JA, Katz AW. Liver Metastasis. In Stereotactic Body Radiation Therapy; Lo S, Teh BS; Lu JJ; Schefter TE, eds. Springer, 2012.
• Kavanagh BD, Lyckholm L, Sugarman J. Ethics, Professional Values, and Legal Considerations in Radiation Oncology. In Principles and Practice of Radiation Oncology, 6th edition, Lippincott, Williams & Wilkins, 2012.
• Kavanagh BD, Bradley J, Timmerman RD. Stereotactic Irradiation of Tumors outside the Central Nervous System. In Principles and Practice of Radiation Oncology, 6th edition, Lippincott, Williams & Wilkins, 2012
• Diot Q, Kavanagh BD, Timmerman RD, Miften M. Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med. Phys. 2012; 39: 237-245.
• Stinauer MA, Diot Q, Westerley DC, Schefter TE, Kavanagh BD. FDG PET response and normal tissue regeneration after stereotactic body radiation therapy to liver metastases. In press, Int J Radiat Oncol Biol Phys 2012.
• Jones BL, Gan G, Diot Q, Kavanagh B, Timmerman RD, Miften M. Dosimetric and Deformation Effects of Image-Guided Interventions during Stereotactic Body Radiation Therapy of the Prostate using an Endorectal Balloon. Med Phys, in press.
• Kavanagh BD, Lyckholm L, Sugarman J. Ethics, Professional Values, and Legal Considerations in Radiation Oncology. In Principles and Practice of Radiation Oncology, 6th edition, Lippincott, Williams & Wilkins, 2012
• Kavanagh BD, Bradley J, Timmerman RD. Stereotactic Irradiation of Tumors outside the Central Nervous System. In Principles and Practice of Radiation Oncology, 6th edition, Lippincott, Williams & Wilkins, 2012
• Stinauer MA, Diot Q, Westerley DC, Schefter TE, Kavanagh BD. Fluorodeoxyglucose positron emission tomography response and normal tissue regeneration after stereotactic body radiation therapy to liver metastases. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e613-618.
• Diot Q, Kavanagh B, Schefter T, Gaspar L, Stuhr K, Miften M Regional Normal Lung Tissue Density Changes in Patients Treated With Stereotactic Body Radiation Therapy for Lung Tumors. Int J Radiat Oncol Biol Phys. Volume 84, Issue 4, 15 November 2012, Pages 1024–1030
• Reddy K, Damek D, Gaspar LE, Ney D, Waziri A, Lillehei K, Stuhr K, Kavanagh BD, Chen C. Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys Volume 84, Issue 3, 1 November 2012, Pages 655–660
• Howells CC, Stinauer MA, Diot Q, Westerly DC, Schefter TE, Kavanagh BD, Miften M. Normal Liver Tissue Density Dose Response in Patients Treated With Stereotactic Body Radiation Therapy for Liver Metastases. Int J Radiat Oncol Biol Phys Volume 84, Issue 3, 1 November 2012, Pages e441–e446
• Westerly DC, Schefter TE, Kavanagh BD, Chao E, Lucas D, Flynn RT, Miften M. l. High-dose MVCT image guidance for stereotactic body radiation therapy. Med Phys. 2012 Aug;39(8):4812-9
• Hartford AC, Galvin JM, Beyer DC, Eichler TJ, Ibbott GS, Kavanagh B, Schultz CJ, Rosenthal SA; American College of Radiology; American Society for Radiation Oncology. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT). Am J Clin Oncol. 2012 Dec;35(6):612-7.
• Weickhardt AJ, Scheier B, Burke JM, Gan G, Lu X, Bunn PA, Aisner DL, Gaspar LE, Kavanagh BD, Doebele RC, Camidge DR. Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene addicted non-small cell lung cancer. J Thorac Oncol. 2012 Dec;7(12):1807-14.
• Kavanagh BD, Ibbott G. Point/Counterpoint: Physicists who are responsible for high-tech radiotherapy procedures should have to be specially credentialed. Med Phys. 2012 Dec;39(12):7181-4
• Cho LC, Timmerman RD, Kavanagh B. Hypofractionated External-Beam Radiotherapy for Prostate Cancer. Prostate Cancer, in revision, 2012.
• Kavanagh BD, Schefter TE. Radiation Therapy for Primary Liver Cancer. In Image-guided Cancer Therapies: A Multiple-disciplinary. William N. McMullen Yuman Fong, MD Gerald Dodd, MD Chul S. Ha, MD Jordan Berlin, MD Ronnie Poon, MD Riccardo Lencioni, eds. Springer, in press, 2011.
• Kavanagh BD, Timmerman RD. Stereotactic Body Radiation Therapy. Principles and Practice in Oncology, Update series, 2011.
• Schefter TE, Kavanagh BD. Radiation Therapy for Liver Metastases, Seminars in Radiation Oncology 2011; 21(4): 264-270.
• Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, Dinniwell R, Brierley J, Kavanagh BD, Dawson LA, Schefter TE. Stereotactic body radiotherapy for colorectal liver metastases: A pooled analysis. Cancer. 2011 Mar 22. doi: 10.1002/cncr.25997. [Epub ahead of print]
• Stinauer MA, Kavanagh BD, Schefter TE, Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M, Raben D. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol. 2011 Apr 8;6(1):34
• Loo BW, Kavanagh B, Meyer JL. Motion Management and Image Guidance for Thoracic TumorRadiotherapy: Clinical Treatment Programs. Front Radiat Ther Oncol 2011; 43: 271–291
• Kavanagh BD, Timmerman R, Meyer JL. The Expanding Roles of Stereotactic Body Radiation Therapy and Oligofractionation: Toward a New Practice of Radiotherapy. Front Radiat Ther Oncol 2011; 43: 370–381
• Heinzerling JH, Kavanagh B, Timmerman RD. Stereotactic ablative radiation therapy for primary lung tumors. Cancer J. 2011 Jan-Feb;17(1):28-32.
• Kavanagh B. Stereotactic Body Radiation Therapy for Early Stage Lung Cancer. Lung Cancer Frontiers, 2011; 43: 1-5
• Guha D, Kavanagh BD. Radiation Toxicity: Avoidance and Amelioration. Seminars in Rad Oncology, in press, 2011.
• Bunn PA, Doebele RC, Miller YE, Peled N, Musani A, Garg K, Franklin W, Hirsch FR, Mitchell JD, Weyant M, Camidge DR, Gaspar L, Kavanagh B, Pugh TJ, Flagiello J, Oton AB. Future direction in the multidisciplinary care of patients with lung cancer. In Lung Cancer, Kernstine KH, Reckapm KL (eds.). New York: Demos Medical Publishing, LLC, 2011.
• Rusthoven K, Kavanagh BD. Metastatic Disease: Overview. In IGRT: A Clinical Perspective, Mundt AJ, Roeske JC, eds. Sheldon, CT: People’s Medical Publishing House-USA, 2011.
• Kavanagh BD, Schefter TE. Radiation Therapy for Primary Liver Cancer. In Image-guided Cancer Therapies: A Multiple-disciplinary. William N. McMullen Yuman Fong, MD Gerald Dodd, MD Chul S. Ha, MD Jordan Berlin, MD Ronnie Poon, MD Riccardo Lencioni, eds. Springer, in press, 2011.
• Amin N, Miften M, Kavanagh B, Raben D, Camidge DR, Thornton D, Rochford N, Gaspar LE. Impact of Induction Chemotherapy on Estimated Risk of Radiation Pneumonitis in Small Cell Lung Cancer. In press, J Thoracic Oncology, 2011.
• Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, Purdie T, Sadagopan R, Schell MC, Salter B, Schlesinger DJ, Shiu AS, Solberg T, Song DY, Stieber V, Timmerman R, Tomé WA, Verellen D, Wang L, Yin F. Stereotactic Body Radiation Therapy: The Report of AAPM Task Group 101. Med Phys. 2010 Aug; 37(8):4078-101
• Zhang L, Kavanagh B, Thorburn A, Camidge DR. Preclinical and Clinical Estimates of a Cancer's Basal Apoptotic Rate Predict for the Amount of Apoptosis Induced by Subsequent Pro-Apoptotic Stimuli. Clin Cancer Res. 2010 Sep 1;16(17):4478-89.
• Rusthoven KE, Olsen C, Franklin W, Kleinschmidt-DeMasters BK, Kavanagh BD, Gaspar LE, Lillehei K, Waziri A, Damek DM, Chen C. Favorable Prognosis in Patients with High-Grade Glioma with Radiation Necrosis: The University of Colorado Denver Re-operation Series. In press, Int J Radiat Oncol Biol Phys.2010 Aug 21. [Epub ahead of print]
• Chen C, Damek D, Gaspar LE, Waziri A, Lillehei K, Kleinschmidt-Demasters BK, Robischon M, Stuhr K, Rusthoven KE, Kavanagh BD. Phase I Trial of Hypofractionated Intensity-Modulated Radiotherapy with Temozolomide Chemotherapy for Patients with Newly Diagnosed Glioblastoma Multiforme. Int J Radiat Oncol Biol Phys. 2010 Oct 5. [Epub ahead of print]
• Fields EC, Damek D, Gaspar LE, Liu AK, Kavanagh BD, Waziri A, Lillehei K, Chen C. Phase I Dose Escalation Trial of Vandetanib With Fractionated Radiosurgery in Patients With Recurrent Malignant Gliomas. Int J Radiat Oncol Biol Phys. 2010 Oct 29. [Epub ahead of print]
• Timmerman RD, Solberg T, Kavanagh BD, Lo S. Stereotactic Techniques for Lung Cancer Treatment. In Principles and Practice of Lung Cancer, 4th edition. Pass HI, Carbone DP, Johnson DH, et al, eds. Philadelphia: Lippincott Williams & Wilkins, 2010.
• Høyer M, Swaminath A, Bydder S, Lock M, Méndez Romero A, Kavanagh B, Goodman KA, Okunieff P, Dawson LA. Radiotherapy for Liver Metastases: A Review of Evidence. IJROBP 2012; 82: 1047–1057.
• Rusthoven C, Carlson JA, Waxweiler TV, Raben D, Dewitt P, Crawford ED, Maroni PD, Kavanagh BD. The Impact of Definitive Local Therapy for Lymph Node-Positive Prostate Cancer: A Population-Based Study. In press, Int J Radiat Oncol Biol Phys
• Vinogradskiy Y, Koo PJ, Castillo R, Castillo E, Guerrero T, Gaspar L, Miften M, Kavanagh B. Comparison of 4DCT-Ventilation with nuclear medicine ventilation-perfusion (VQ) imaging: a clinical validation study. In press, Int J Radiat Oncol Biol Phys
• Kim N, Cho LC, Straka C, Christie A, Lotan Y, Pistenmaa D, Kavanagh BD, Nanda A, Kupelian P, Brindle J, Cooley S, Perkins A, Raben D, Xie X-J, Timmerman RD. Specific Causal Injury Mechanisms May Predict General Rectal Tolerance Effects in a Phase I/II Study of Stereotactic Body Radiation Therapy for Prostate Cancer. In press, Int J Radiat Oncol Biol Phys.
• Mohideen N, Kavanagh BD, Beyer D, Madhani S, Steinberg M. The Radiation Oncology Perspective on Health Reform and Value Based Initiatives. J Oncol Practice, 2014, in press

Professional Memberships

• American Society for Radiation Oncology, Chair, 2017-

Practice Locations

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

CU Medicine Radiation Oncology - Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 101
Highlands Ranch, CO 80129
720-516-0150

UCHealth Radiation Oncology - Cherry Creek Medical Center
100 Cook Street
Suite 102
Denver, CO 80206
720-516-9422

UCHealth Radiation Oncology - Longs Peak Medical Center
1760 E. Ken Pratt Boulevard
Suite 105 Longmont
Longmont, CO 80504
720-848-0100

Rocky Mountain Gamma Knife Center - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-1290

UCHealth Radiation Oncology - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0100

Hospital Affiliation

• University of Colorado Hospital
• UCHealth Highlands Ranch Hospital

Center Affiliations

• University of Colorado Cancer Center

Specialty Information

Specialties

• Radiation Oncology, Board Certification (1993)

Conditions & Treatments

• Cancers - Radiation Therapy
• Cancers